New patent for Astrazeneca drug LYNPARZA

April 7, 2022 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for LYNPARZA Lynparza is a drug marketed by Astrazeneca and is included in two NDAs. It is available from one supplier. There are eleven patents protecting…

The post New patent for Astrazeneca drug LYNPARZA appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.